Compound Screening TRIZ Cases

Detecting SSEA-3-positive Muse cells via flow cytometry overcomes the 4.5-hour thrombolytic window by enabling early cerebral infarction diagnosis.

Screening assay identifies compounds stabilizing gamma-secretase enzyme-substrate complexes under thermal stress conditions.

Screening antibody variants via flow cytometry identifies candidates with decreased binding to anti-idiotypic antibodies.

Fluorescent membrane potential dyes measure TRPM5 activity to resolve low specificity and throughput bottlenecks in compound screening.

VEGF-C agonists restore lymphatic function by reducing VEGF-A activity, preventing UVB-induced hyperpermeability and edema.

IgG-coated beads remove interfering anti-CD38 antibodies from patient serum for accurate crossmatching.

A microwave-accelerated metal-enhanced fluorescence assay system enables rapid detection of anthrax protective antigen using silver island films.

Homogeneous reporters resolve variability in dual-triple systems, enabling direct quantification of multiple transcription factors.

Reagent loading device protrusions deliver test agents simultaneously to multiple wells, reducing repetitive pipetting time.

A universal parameter calculation method measures Factor Xa activity in body fluid samples to determine anticoagulant levels.

Trans-cinnamoyl derivatives inhibit transglutaminase via reversible competitive binding at the active site.

CDK12 amplification predicts trastuzumab resistance, enabling CDK12 kinase inhibition to restore sensitivity.

EMI scoring system evaluates skin surface isotropy using scanning electron microscopy to assess cellular organization and maturation levels.

Engineered plant cystatin scaffolds maintain structural integrity during peptide display, resolving deformation issues in prior art frameworks.

Blocking TLR2 signaling reduces liver metastasis and improves survival in pancreatic cancer.

Specific CDR sequences modify Bak conformation to activate apoptosis, resolving the lack of effective activating antibodies.

CRISPR-Cas9 editing activates endogenous RTP1 genes in mammalian cell lines to support odorant receptor function.

Leucine binding to Sestrin2 disrupts the GATOR2-Sestrin interaction, resolving amino acid response contradictions in mTORC1 signaling.

Antisense oligonucleotides block NMD-inducing exon 3a splicing, raising RBM3 expression without hypothermia risks.

Saposin lipoprotein particles solubilize membrane proteins while preserving their native structure, overcoming detergent-induced denaturation.

Recombinant serine protease inhibitors block kallikrein activity to restore skin barrier function, avoiding steroid side effects.

Chimeric proteins bridge in vitro and in vivo gaps, enabling cell-based assays that assess compound permeability and toxicity while reducing reagent costs.

Oligodendrocyte progenitor cells expressing PCNT resolve stem cell survival and rejection trade-offs in central nervous system disease therapy.

CPC TRPA1 receptor antagonists block cetyl pyridinium chloride activation, resolving taste aversion while maintaining breath malodor control.

Immortalized EBV-transformed B cell lines produce affinity-matured human antibodies directly from polynucleotide libraries.

Detect EGFR mutations in exons 18-21 using nucleic acid probes to identify tumors susceptible to kinase inhibitors and avoid chemoresistance.

Serial passage of filoviruses in outbred guinea pigs generates uniformly lethal strains that replicate severe coagulopathy and vascular leak syndromes.

Targeting TgIF2K-D kinase activity disrupts extracellular parasite stress responses, reducing infectivity without anti-folate toxicity.

Akt inhibitors target constitutive Akt activation to kill seborrheic keratosis cells while sparing normal keratinocytes.

Detecting premature mitochondrial proteins confirms Alzheimer's disease in living patients, resolving the need for invasive post-mortem examination.

A method differentiating monocytes into functional neuronal-like cells using specific growth factors.

A voltage-dependent cation channel substrate enables objective screening of olfactory sensitivity inhibitors through electrical activity measurement.

Diagnostic methods detect specific Smoothened mutations enabling selection of effective Hedgehog pathway inhibitors to treat resistant tumors.

Replacing species-specific fluorescence with universal respiration monitoring enables continuous defense priming detection across plant and animal cell types.

RET ligands discriminate G protein states without radioactive materials or fusion proteins.

Bypasses the protective cuticula and reduces feeding requirements by using the nephropore as an intermediary portal for efficient virus transmission.

Antibodies targeting Nogo and Caspr proteins stimulate oligodendrocyte maturation to promote axonal myelination.

γc-cytokine antagonist peptides inhibit IL-2, IL-9, and IL-15 signaling to treat cytokine-release syndrome without broad immune suppression.

An integrin beta fragment binds to sPLA2-IIA at site 2, blocking the interaction between the enzyme and cell surface receptors to suppress inflammation.

Nanodiscs stabilize the NALCN-FAM155A-UNC79-UNC80 complex for modulator screening.

Segmented genetic analysis detects copy number alterations with array CGH and FISH, resolving imprecise diagnosis of hematological malignancies.

Single-nucleus RNA-seq profiles malignant cell signatures in pancreatic ductal adenocarcinoma tumors, resolving dense desmoplastic stroma interference.

Segmented peptide assays detect specific kinases modifying tau protein to resolve identification precision and targeting reliability trade-offs.

A periostin protein measurement method detects idiopathic interstitial pneumonia using immunoassays on biological samples.

BMP6 antagonists inhibit this transfer pathway, resolving adverse effects from broad melanogenesis targeting.

A prorenin receptor antibody binds specific amino acid residues to detect cancer biomarkers in biological specimens.